Demystified ... Tissue microarray technology

被引:102
作者
Packeisen, J
Korsching, E
Herbst, H
Boecker, W
Buerger, H
机构
[1] Klinikum Osnabrueck, Dept Pathol, D-49076 Osnabruck, Germany
[2] Univ Hosp Munster, Inst Pathol, D-48149 Munster, Germany
来源
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY | 2003年 / 56卷 / 04期
关键词
D O I
10.1136/mp.56.4.198
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Several "high throughput methods" have been introduced into research and routine laboratories during the past decade. Providing a new approach to the analysis of genomic alterations and RNA or protein expression patterns, these new techniques generate a plethora of new data in a relatively short time, and promise to deliver clues to the diagnosis and treatment of human cancer. Along with these revolutionary developments, new tools for the interpretation of these large sets of data became necessary and are now widely available. Tissue microarray (TMA) technology is one of these new tools. It is based on the idea of applying miniaturisation and a high throughput approach to the analysis of intact tissues. The potential and the scientific value of TMAs in modern research have been demonstrated in a logarithmically increasing number of studies. The spectrum for additional applications is widening rapidly, and comprises quality control in histotechnology, longterm tissue banking, and the continuing education of pathologists. This review covers the basic technical aspects of TMA production and discusses the current and potential future applications of TMA technology.
引用
收藏
页码:198 / 204
页数:7
相关论文
共 29 条
[1]   Towards a novel classification of human malignancies based on gene expression patterns [J].
Alizadeh, AA ;
Ross, DT ;
Perou, CM ;
van de Rijn, M .
JOURNAL OF PATHOLOGY, 2001, 195 (01) :41-52
[2]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[3]  
BATTIFORA H, 1986, LAB INVEST, V55, P244
[4]  
Brandt B, 2002, CANCER RES, V62, P1020
[5]   Tissue microarray (TMA) technology:: miniaturized pathology archives for high-throughput in situ studies [J].
Bubendorf, L ;
Nocito, A ;
Moch, H ;
Sauter, G .
JOURNAL OF PATHOLOGY, 2001, 195 (01) :72-79
[6]  
Chan J K, 2000, Ann Diagn Pathol, V4, P329, DOI 10.1053/adpa.2000.17892
[7]   Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins [J].
Fejzo, MS ;
Slamon, DJ .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (05) :1645-1650
[8]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[9]   Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry [J].
Hsu, FD ;
Nielsen, TO ;
Alkushi, A ;
Dupuis, B ;
Huntsman, D ;
Liu, CL ;
van de Rijn, M ;
Gilks, CB .
MODERN PATHOLOGY, 2002, 15 (12) :1374-1380
[10]  
INCE TA, 2002, CANCER CELL, V1, P23